Jiangsu Cowin Biotech Co (SHSE:688426) ROCE % : -8.13% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangsu Cowin Biotech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -8.13%.

Jiangsu Cowin Biotech Co ROCE % Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co ROCE % Chart

Jiangsu Cowin Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.13

49.69

28.42

16.11

-5.07

Jiangsu Cowin Biotech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial											1.84	-1.43	-5.58	-15.50	-8.13

Jiangsu Cowin Biotech Co ROCE % Calculation

Jiangsu Cowin Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-91.288	/	( ( (1955.26 - 93.148)	+	(1822.219 - 84.862) )	/ 2 )
	=	-91.288	/	( (1862.112	+	1737.357)	/ 2 )
	=	-91.288	/	1799.7345
	=	-5.07 %

Jiangsu Cowin Biotech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-139.812	/	( ( (1822.219 - 84.862)	+	(1772.179 - 70.469) )	/ 2 )
	=	-139.812	/	( ( 1737.357	+	1701.71 )	/ 2 )
	=	-139.812	/	1719.5335
	=	-8.13 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Jiangsu Cowin Biotech Co (SHSE:688426) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangsu Cowin Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Cowin Biotech Co (SHSE:688426) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300

Website

https://www.cwbio.com

Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.

Executives

Yin Jian Feng	Director
Zhuang Zhi Hua	Directors, senior managers

Jiangsu Cowin Biotech Co (SHSE:688426) Headlines

No Headlines